Jones Financial Companies
ALT icon

Jones Financial Companies’s Altimmune ALT Stock Holding History

Jones Financial Companies’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6K Sell
10,156
-15,713
-61% -$46.9K ﹤0.01% 3352
2026
Q1 		$78.1K Buy
25,869
+13,343
+107% +$56.7K ﹤0.01% 2769
2025
Q4 		$45.2K Buy
12,526
+5,900
+89% +$25.7K ﹤0.01% 2575
2025
Q3 		$26.5K Hold
6,626
– – ﹤0.01% 2653
2025
Q2 		$23.2K Buy
6,626
+993
+18% +$5.37K ﹤0.01% 2529
2025
Q1 		$30K Buy
+5,633
New +$35.7K ﹤0.01% 2272

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's ALT Position: Q2 2026 in Review

Jones Financial Companies reduced its Altimmune (ALT) stake by 61% in Q2 2026, selling an estimated $46.9K and leaving 10,156 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3352.

Jones Financial Companies first reported a position in ALT in Q1 2025 and has held it in 6 quarters since. The position peaked at $78.1K in Q1 2026. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Jones Financial Companies held 10,156 shares of Altimmune worth $28.6K as of Q2 2026.
  • Jones Financial Companies sold 15,713 Altimmune shares in Q2 2026, an estimated $46.9K.
  • Altimmune made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3352 holding.
  • Jones Financial Companies first reported a position in Altimmune in Q1 2025 and has held it in 6 quarters since.
  • Jones Financial Companies's Altimmune position peaked at $78.1K in Q1 2026.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.